Patents by Inventor Terry Crawford
Terry Crawford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11992605Abstract: A vapor cartridge for a non-combustible vaping device may be configured to receive a flavor cartridge, generate a vapor, and direct the generated vapor through the flavor cartridge to provide a flavored vapor. The flavor cartridge may include an instance of electrically conductive material extending at least partially around the flavor cartridge. The vapor cartridge may include an authentication assembly including a set of electrically conductive instruments may independently and directly contact the instance of electrically conductive material of the flavor cartridge inserted into the vapor cartridge, such that the electrically conductive instruments are electrically connected to each other through the instance of electrically conductive material of the flavor cartridge.Type: GrantFiled: October 5, 2021Date of Patent: May 28, 2024Assignee: Altria Client Services LLCInventors: Terry Bache, Ryan Newcomb, Eric A. Hawes, Dmitriy Kirzhner, Raymond Lau, Danielle Crawford, Dwight D. Williams, William Eugene Rabbitt, Carl Roy Stevens
-
Patent number: 11950622Abstract: The method includes providing a filler material that is water insoluble, the providing provides the filler material with more than 98% alpha-cellulose, 0.01% to less than 2% ash and a remainder hemicellulose, infusing at least one first consumable within the filler material and inserting a matrix within at least one first containing structure to form a capsule, the matrix including the filler material.Type: GrantFiled: September 2, 2022Date of Patent: April 9, 2024Assignee: Altria Client Services LLCInventors: Munmaya K. Mishra, Danielle Crawford, Dwight David Williams, Eric Hawes, Terry Bache, Raymond W. Lau, Shaoyong Yu
-
Patent number: 11195556Abstract: An approach is provided for a segment-based viewing of a watermarked recording. The approach involves receiving a request, from an evaluator, to access one of a plurality of media associated with a plurality of interviewees, wherein each of the plurality of media represents a recording of an interview of a corresponding interviewee; and wherein the request relates to evaluation of the corresponding interviewee for admission or hiring. The approach also involves determining source-identifying information associated with the evaluator. The approach further involves determining source-identifying information associated with the request. The approach additionally involves generating a watermark based on the source-identifying information, wherein the watermark is configured to depict an identifier of the evaluator during a presentation of the requested media. The approach further involves modifying the one media to superimpose the watermark on the recording.Type: GrantFiled: May 13, 2020Date of Patent: December 7, 2021Inventor: Terry Crawford
-
Publication number: 20200273496Abstract: An approach is provided for a segment-based viewing of a watermarked recording. The approach involves receiving a request, from an evaluator, to access one of a plurality of media associated with a plurality of interviewees, wherein each of the plurality of media represents a recording of an interview of a corresponding interviewee; and wherein the request relates to evaluation of the corresponding interviewee for admission or hiring. The approach also involves determining source-identifying information associated with the evaluator. The approach further involves determining source-identifying information associated with the request. The approach additionally involves generating a watermark based on the source-identifying information, wherein the watermark is configured to depict an identifier of the evaluator during a presentation of the requested media. The approach further involves modifying the one media to superimpose the watermark on the recording.Type: ApplicationFiled: May 13, 2020Publication date: August 27, 2020Inventor: Terry CRAWFORD
-
Patent number: 10358437Abstract: The present invention relates to methods for treating PCAF mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1, R3-R6, X, and each Re have any of the values defined in the specification. Also included are novel compounds of formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.Type: GrantFiled: March 3, 2017Date of Patent: July 23, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew Charles Good, Yves LeBlanc, Steven Magnuson, Christopher G. Nasveschuk, Richard Pastor, F. Anthony Romero, Alexander M. Taylor
-
Patent number: 10316023Abstract: The present invention relates to methods for treating PCAF mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1, R3-R6, X, and each Re have any of the values defined in the specification. Also included are novel compounds of formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.Type: GrantFiled: March 3, 2017Date of Patent: June 11, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew Charles Good, Yves LeBlanc, Steven Magnuson, Christopher G. Nasveschuk, Richard Pastor, F. Anthony Romero, Alexander M. Taylor
-
Patent number: 10308614Abstract: The present invention relates to compounds of formula (I): and salts thereof, wherein: R1-R4 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of BRG1, BRM and/or PB1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various BRG1-mediated disorders, BRM-mediated disorders and/or PB1-mediated disorders.Type: GrantFiled: August 24, 2017Date of Patent: June 4, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew Charles Good, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, F. Anthony Romero, Yong Tang, Alexander M. Taylor
-
Patent number: 10258603Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1, R2, Rc, and Rd have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.Type: GrantFiled: May 10, 2017Date of Patent: April 16, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Steven F. Bellon, Daniel J. Burdick, Alexandre Cote, Terry Crawford, Les A. Dakin, Vickie Hsiao-Wei Tsui, Michael Charles Hewitt, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, F. Anthony Romero, Yong Tang, Alexander M. Taylor, Shumei Wang
-
Patent number: 10206931Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein A has any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.Type: GrantFiled: April 7, 2017Date of Patent: February 19, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: F. Anthony Romero, Steven R. Magnuson, Richard Pastor, Vickie Hsiao-Wei Tsui, Jeremy Murray, Terry Crawford, Daniel J. Burdick, Brian K. Albrecht, Alexandre Cote, Alexander M. Taylor, Christopher G. Nasveschuck, Yves LeBlanc, Michael Charles Hewitt, Kwong Wah Lai, Kevin Chen
-
Patent number: 10202378Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.Type: GrantFiled: July 24, 2017Date of Patent: February 12, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Marc Adler, Daniel J. Burdick, Terry Crawford, Martin Duplessis, Steven R. Magnuson, Christopher G. Nasveschuk, F. Anthony Romero, Yong Tang, Vickie Hsiao-Wei Tsui, Shumei Wang
-
Patent number: 10203853Abstract: An approach for providing segment-based viewing of recorded sessions is described. A video platform may determine one or more segments of a communication session based on content of the communication session. The video platform may also associate one or more segments with a recording of the communication session. The video platform may cause, at least in part, a presentation of the recording and one or more indicators for navigating playback of the recording based on the one or more segments, wherein the one or more indicators correspond to the one or more segments.Type: GrantFiled: October 23, 2017Date of Patent: February 12, 2019Inventor: Terry Crawford
-
Patent number: 10183009Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1, R2, and Q have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.Type: GrantFiled: May 10, 2017Date of Patent: January 22, 2019Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Steven F. Bellon, Daniel J. Burdick, Alexandre Cote, Terry Crawford, Les A. Dakin, Vickie Hsiao-Wei Tsui, Michael Charles Hewitt, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, F. Anthony Romero, Yong Tang, Alexander M. Taylor, Shumei Wang
-
Patent number: 10155764Abstract: The present invention relates to methods for treating PCAF and GCN5 mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein ring A, R1, R3, R4, R5, and each Re have any of the values defined in the specification. Also included are novel compounds of Formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.Type: GrantFiled: March 3, 2017Date of Patent: December 18, 2018Assignees: GENENTECH, INC, CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew Charles Good, Yves LeBlanc, Steven Magnuson, Christopher G. Nasveschuk, Richard Pastor, Anthony F. Romero, Alexander M. Taylor
-
Patent number: 10150767Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1, R2, and Q have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.Type: GrantFiled: May 10, 2017Date of Patent: December 11, 2018Assignees: Genentech, Inc., Constellation Pharmaceuticals Inc.Inventors: Brian K. Albrecht, Steven F. Bellon, Daniel J. Burdick, Alexandre Cote, Terry Crawford, Les A. Dakin, Vickie Hsiao-Wei Tsui, Michael Charles Hewitt, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, Anthony F. Romero, Yong Tang, Alexander M. Taylor, Shumei Wang
-
Publication number: 20180308520Abstract: An approach is provided for a segment-based viewing of a watermarked recording. The approach involves storing a plurality of media associated with a plurality of interviewees, wherein each of the plurality of media represents a recording of an unscripted interview of a corresponding interviewee. The approach also involves receiving a request to access one of the plurality of media. The approach further involves determining source-identifying information associated with the request. The approach additionally involves generating a watermark based, at least in part, on the source-identifying information. The approach further involves modifying the one media to superimpose the watermark on the recording. The approach also involves initiating transmission of the modified media to a target device.Type: ApplicationFiled: April 25, 2018Publication date: October 25, 2018Inventor: Terry CRAWFORD
-
Publication number: 20180086720Abstract: The present invention relates to compounds of formula (I): and salts thereof, wherein: R1-R4 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of BRG1, BRM and/or PB1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various BRG1-mediated disorders, BRM-mediated disorders and/or PB1-mediated disorders.Type: ApplicationFiled: August 24, 2017Publication date: March 29, 2018Applicants: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Alexandre Cote, Terry Crawford, Martin Duplessis, Andrew Charles Good, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, Anthony F. Romero, Yong Tang, Alexander M. Taylor
-
Publication number: 20180046360Abstract: An approach for providing segment-based viewing of recorded sessions is described. A video platform may determine one or more segments of a communication session based on content of the communication session. The video platform may also associate one or more segments with a recording of the communication session. The video platform may cause, at least in part, a presentation of the recording and one or more indicators for navigating playback of the recording based on the one or more segments, wherein the one or more indicators correspond to the one or more segments.Type: ApplicationFiled: October 23, 2017Publication date: February 15, 2018Inventor: Terry CRAWFORD
-
Publication number: 20180009805Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.Type: ApplicationFiled: July 24, 2017Publication date: January 11, 2018Applicants: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Marc Adler, Daniel J. Burdick, Terry Crawford, Martin Duplessis, Steven R. Magnuson, Christopher G. Nasveschuk, Anthony F. Romero, Yong Tang, Vickie Hsiao-Wei Tsui, Shumei Wang
-
Patent number: 9855269Abstract: The invention provides a method of inhibiting angiogenesis in a patient by administering a compound of formula (I): wherein R1 R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.Type: GrantFiled: March 9, 2017Date of Patent: January 2, 2018Assignee: Genentech, Inc.Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Nbdubaku, Lan Wang
-
Publication number: 20170340605Abstract: The present invention relates to compounds of formula (I): and to salts thereof, wherein R1, R2, and Q have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.Type: ApplicationFiled: May 10, 2017Publication date: November 30, 2017Applicants: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.Inventors: Brian K. Albrecht, Steven F. Bellon, Daniel J. Burdick, Alexandre Cote, Terry Crawford, Les A. Dakin, Vickie Hsiao-Wei Tsui, Michael Charles Hewitt, Yves LeBlanc, Steven R. Magnuson, Christopher G. Nasveschuk, Anthony F. Romero, Yong Tang, Alexander M. Taylor, Shumei Wang